BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI)

CUSIP: 10501E300

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, $0.00005 par value
Shares outstanding
6,002,966
Total 13F shares
2,317
Share change
-233,437
Total reported value
$1,727
Price per share
$0.71
Number of holders
5
Value change
-$261,339
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 10501E300?
CUSIP 10501E300 identifies BCLI - BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) as of Q3 2025

As of 30 Sep 2025, BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,317 shares. The largest 5 holders included OSAIC HOLDINGS, INC., Bangor Savings Bank, VSM Wealth Advisory, LLC, Steward Partners Investment Advisory, LLC, and ST GERMAIN D J CO INC. This page lists 5 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.